Business Wire

ADVA

6.5.2021 09:02:06 CEST | Business Wire | Press release

Share
METRO-HAUL demo uses ADVA’s FSP 3000 OLS in public safety showcase

ADVA (FSE: ADV) today announced that its FSP 3000 open line system (OLS) played a key role in a demo showcasing a real-time public safety application. In the METRO-HAUL field trial, AI-based thermal-imaging and pan-tilt-zoom video cameras were used to secure a surveillance area. Advanced video analytics and active camera control require the transport of high-bandwidth video and latency-critical control traffic to a remote control center. Using the ADVA FSP 3000 OLS with flexible micro-ROADMs as well as QuadFlex™ transponders, the demo featured a programmable metro network with edge nodes for time-critical computing. Conducted at Fraunhofer HHI’s test beds in Berlin as part of the 5G Infrastructure Public Private Partnership (5G PPP) initiative’s METRO-HAUL project, the trial involved ADVA and several research center and university partners.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210506005044/en/

“This METRO-HAUL demo reveals how modern metro networks with edge compute and storage functionality can support intelligent video surveillance systems to provide unprecedented power and efficiency. It also highlights how important network slicing will be in enabling the agile resource allocation needed to support high-bandwidth, ultra-low-latency applications such as automated object detection and tracking,” said Achim Autenrieth, director, advanced technology, ADVA. “Built on our FSP 3000 OLS with flexible micro-ROADMs and SDN control, this showcase highlights just how much operators can now achieve by deploying disaggregated 5G infrastructure with edge computing and network slicing capabilities. It illustrates that next-generation metro networks are ready to support a new breed of high-bandwidth, low-latency applications and take safety surveillance technology to the next stage.”

In the METRO-HAUL field trial, application-aware network slicing was used for prioritized transport of critical real-time video streams. Object tracking was performed by a video management and analytics service running locally as a virtual network function, and instantiated ad-hoc on an edge-compute-enabled metro node. The demo showed a high-definition video stream automatically tracing any object crossing the perimeter of the surveillance zone. The stream was then distributed to a central location for real-time analysis and remote incident control. Managed by ADVA’s Ensemble Controller with its proven SDN domain controller, the test network enabled rapid provisioning of high-bandwidth resources and offered end-to-end latency awareness. Flexible connectivity was provided by coherent transponders and an innovative ROADM-based OLS architecture optimized for metro network demands. The demo was selected as one of the Top 10 5G PPP Infrastructure Trials and Pilots.

“Alongside partners like ADVA, we’ve been working to rapidly develop transport network slicing and open the door to a world of new applications. Enabling multi-access edge computing right where it’s needed will be key to many emerging use cases. This METRO-HAUL field trial harnessing ADVA’s open transport technology shows how it’s now possible to create flexible end-to-end architectures that interface with both 5G access and multi-Tbit elastic core networks,” said Andrew Lord, senior manager, optical research, BT. “Right now, digitalization and 5G are transforming nearly every industry, and the impact on public safety technology will be hugely significant. As ADVA’s showcase proves, tomorrow’s networks will take speed, low latency, reliability and agility to the next level, enabling mission-critical security services to process, store and analyze more data and deliver more value than ever before.”

The results from the demo will be presented at the OFC 2021 technical conference on Friday, June 11 at 11 a.m. (PDT), Session ID - F4H.2: https://adva.li/ofc21-latency-aware-demo .


About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .

Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com

Social Media:

https://www.facebook.com/ADVAOpticalNetworking

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 15:00:00 CEST | Press release

New Washington State facility provides capacity to manufacture more than 30,000 radars annually, strengthening the U.S. defense industrial base As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructu

Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 15:00:00 CEST | Press release

Analysis of more than 1,200 production cloud environments provides a first-hand view into how organizations are embedding AI into business-critical workflows, exposing new security risks that traditional controls weren't built to address. Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become ope

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 15:00:00 CEST | Press release

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai's health system network Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's co

SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release

The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/

Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release

Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye